Mastercard announced that its Chief Financial Officer, Sachin Mehra, has informed the Mastercard board and his colleagues that he will be undergoing treatment for non-Hodgkin lymphoma. “It was detected very early, with scans and biopsies indicating it is highly localized and curable. With the recommended treatment, Sachin’s long-term prognosis is excellent. He will remain actively involved in daily operations, working remotely for the coming months,” the company said in a statement.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MA:
- M&A News: Mastercard (NYSE:MA) Set to Acquire Recorded Future for $2.65B
- MasterCard to acquire Recorded Future from Insight Partners for $2.65B
- Mastercard Stock (NYSE:MA) Sees Sustained Growth that Fuels Share Price Gains
- Alibaba to offer U.S. credit card for businesses with Mastercard
- Alibaba (NYSE:BABA) Launches AI Sourcing Agent to Boost Global Trade
